Sunday, 31 March 2019

JINDAL HOTEL

JINDAL HOTELS LTD (Face Value: Rs.10) :-
 Jindal Hotels Limited engages in the hotel business in India. The company operates Grand Mercure Vadodara Surya Palace hotel located in Vadodara, as well as Azure restaurant. Its hotel has various facilities, such as 143 guest rooms, 6 large and medium banquet halls, board room, restaurant, swimming pool, health club, liquor shop, and other amenities. It has an equity capital of just Rs.6crore and reserves of Rs.19.35crore. The promoter holds 64.33% 
while the investing public holds 35.57% stake in the company. Promoters increased their stake by 2.91% during July-December-18 which is positive sign. During 9MFY19, its net profit soared 9611% to Rs.0.87crore from Rs.0.01crore in 9MFY18 on higher income of Rs.27.25crore fetching an EPS of Rs.1.46. Stock was traded at Rs.88 levels in May 2018 and stock almost corrected 52% from recent high. Everyone, whose financial advisor is allowing to trade in this stock for medium to long term can watch with a stop loss of Rs.35. 

Good evening Friends

Lambodhara Tex. CMP: Rs.44.95
Coimbatore based Lambodhara Textiles Ltd was founded in 1994 with a capacity of 3,024 spindles. Over the years the company has grown in size and currently has a capacity of 37,856 spindles, with 33,224 spindles producing fancy yarns. The mill is fully modernized with state of art technology and infrastructure. Company produce yarns in a count range from 10s to 60s. Company specializes in manufacturing slub yarns, multi count and multi twist yarns, siro yarns and neppy yarns. It produce yarns using Polyester, Polyester variants, Viscose, Modal, Excel and Flax as raw materials. It has an equity capital of just Rs.4.79crore supported by reserves of around Rs.45.34crore.
The promoters hold 70.11% of the equity capital, which leaves 29.89% stake with the investing public. Its share book value works out to Rs.52.34 and the price to book value ratio stands at just 0.85x. For 9MFY19, it has reported PAT of Rs.5.40 crore on higher sales of Rs.130.27 crore fetching an EPS of Rs.5.63.
 Currently, the stock trades at a P/E of just 7.3x. It is regular dividend paying company and it has paid 20% dividend for FY18. In February 2018, Company has allotted 5,00,000 Equity Shares to Promoters at a face value of Rs.5/- each and premium of Rs.75. Its 52 week high rate is Rs.87.9 which was formed on 23rd April 2018. Stock almost corrected 50% from 52 week high. Investors can accumulate this stock with a stop loss of Rs.37. It may give very good returns in medium to long term

Friday, 29 March 2019

Good morning Friends--

DEAR  ONCE AGAIN I AM REPEATING -- MAXIMAA SYSTEMS LTD  --THIS IS A LOW PRICE  STOCK  BUT YOU INVEST IN FOR 2 YRS  THEN YOU WILL REALISE . SOMETHING  IS COOKING IN THIS, COMPANY IS GOING TO DEVELOPING HIS  PHARMA DIVISION SO  IT WILL GIVE  HANDSOME  RETURN ...
                                                                                  THATSALL

Monday, 25 March 2019

BUY ONE ANOTHER NICE STOCK ---PORWAL AUTO--

THIS IS THE  RIGHT TIME TO CHOOSE  AND  BUY THE  GOOD STOCK  FROM   MIDCAP  AND SMALL CAP .

 Porwal  Auto   is moving north wards.It is multybagger share, one can buy and keep for  18 TO  24  Months, it will give good returns.It is my opinion.you can research on your own and give your opinion on this share.

Good morning Friends

Now I am again saying  for  --MAXIMAA SYSTEMS LTD-- IT  WILL  GIVE YOU BIG REWARD,  so  you invest in for 2  to  3  yrs.  Merging  demerging  will see  in this stock   near  future. 
                                                                                 
 ------ BUY  EVERY FALL  THATS ALL    -----       



                  

Friday, 15 March 2019

Tuesday, 12 March 2019

Monday, 11 March 2019

Kriti Nutrient

Friends my opinion is that you watch this stock it will go up .

                                           OK

Good morning friends

ANG Lifesciences ((Rs. 33.00) (Code: 540694) It makes finished pharmaceutical formulations
and sterile dry power injection vials in dosage form. It has a modern plant, equipment, technology
and manpower. Its plants are GMP certified. It makes sterile dry power vials for anti biotics, anti
ulcerant, gluco corticoid, and anti inflammatory, anti malarial, and anaesthetic products. Its clients
include Wockhardt, DHS Maharashtra, Global Hospitals, etc. The company had issued shares at
Rs. 80 in 2017, which had got listed at Rs. 96. The stock is now available at a steep discount. Profit
for 12-month period was Rs. 3.27 crores and Rs. 2.71 crores for six months. It will be mulit-bagger in future .
                 THANKS

Subscribe to: Posts (Atom)